GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Respiratorius AB (XSAT:RESP) » Definitions » Scaled Net Operating Assets

Respiratorius AB (XSAT:RESP) Scaled Net Operating Assets : 0.92 (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Respiratorius AB Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Respiratorius AB's operating assets for the quarter that ended in Dec. 2024 was kr31.02 Mil. Respiratorius AB's operating liabilities for the quarter that ended in Dec. 2024 was kr0.92 Mil. Respiratorius AB's Total Assets for the quarter that ended in Sep. 2024 was kr32.88 Mil. Therefore, Respiratorius AB's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.92.


Respiratorius AB Scaled Net Operating Assets Historical Data

The historical data trend for Respiratorius AB's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Respiratorius AB Scaled Net Operating Assets Chart

Respiratorius AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 0.94 0.43 0.69 1.08

Respiratorius AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Apr22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.82 0.89 0.96 1.19 0.92

Competitive Comparison of Respiratorius AB's Scaled Net Operating Assets

For the Biotechnology subindustry, Respiratorius AB's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Respiratorius AB's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Respiratorius AB's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Respiratorius AB's Scaled Net Operating Assets falls into.



Respiratorius AB Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Respiratorius AB's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(31.015-0.92)/27.77
=1.08

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=31.015 - 0
=31.015

Respiratorius AB's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(31.015-0.92)/32.875
=0.92

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=31.015 - 0
=31.015

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Respiratorius AB Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Respiratorius AB's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Respiratorius AB Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Respiratorius AB develops pharmaceutical drugs to treat the common diseases namely Cancer, Chronic Obstructive Pulmonary Disease (COPD), and asthma as well as better methods for diagnosing cardiovascular diseases. The company's drug candidates includes RCD405, VAL001, RESP2000, RESP3000, RESP9000, and RESP1000.

Respiratorius AB Headlines

No Headlines